Cargando…

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells

Detalles Bibliográficos
Autores principales: Chin, Li-Han, Hsu, Sung-Po, Zhong, Wen-Bin, Liang, Yu-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421810/
https://www.ncbi.nlm.nih.gov/pubmed/28481927
http://dx.doi.org/10.1371/journal.pone.0177545
_version_ 1783234653847552000
author Chin, Li-Han
Hsu, Sung-Po
Zhong, Wen-Bin
Liang, Yu-Chih
author_facet Chin, Li-Han
Hsu, Sung-Po
Zhong, Wen-Bin
Liang, Yu-Chih
author_sort Chin, Li-Han
collection PubMed
description
format Online
Article
Text
id pubmed-5421810
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54218102017-05-14 Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells Chin, Li-Han Hsu, Sung-Po Zhong, Wen-Bin Liang, Yu-Chih PLoS One Correction Public Library of Science 2017-05-08 /pmc/articles/PMC5421810/ /pubmed/28481927 http://dx.doi.org/10.1371/journal.pone.0177545 Text en © 2017 Chin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Chin, Li-Han
Hsu, Sung-Po
Zhong, Wen-Bin
Liang, Yu-Chih
Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
title Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
title_full Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
title_fullStr Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
title_full_unstemmed Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
title_short Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
title_sort correction: combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421810/
https://www.ncbi.nlm.nih.gov/pubmed/28481927
http://dx.doi.org/10.1371/journal.pone.0177545
work_keys_str_mv AT chinlihan correctioncombinedtreatmentwithtroglitazoneandlovastatininhibitedepidermalgrowthfactorinducedmigrationthroughthedownregulationofcysteinerichprotein61inhumananaplasticthyroidcancercells
AT hsusungpo correctioncombinedtreatmentwithtroglitazoneandlovastatininhibitedepidermalgrowthfactorinducedmigrationthroughthedownregulationofcysteinerichprotein61inhumananaplasticthyroidcancercells
AT zhongwenbin correctioncombinedtreatmentwithtroglitazoneandlovastatininhibitedepidermalgrowthfactorinducedmigrationthroughthedownregulationofcysteinerichprotein61inhumananaplasticthyroidcancercells
AT liangyuchih correctioncombinedtreatmentwithtroglitazoneandlovastatininhibitedepidermalgrowthfactorinducedmigrationthroughthedownregulationofcysteinerichprotein61inhumananaplasticthyroidcancercells